• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

教育模块对急诊医师开具丁丙诺啡/纳洛酮治疗阿片类药物使用障碍知识和态度的影响。

Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine/Naloxone for Opioid Use Disorder.

出版信息

J Opioid Manag. 2024 Jul-Aug;20(4):B13. doi: 10.5055/bupe.24.rpj.1095.

DOI:10.5055/bupe.24.rpj.1095
PMID:39321067
Abstract

BACKGROUND

Opioid overdose continues to be a major cause of morbidity and mortality. Buprenorphine is an important treatment for patients with opioid-use disorder (OUD) and initiation in the emergency department (ED) has been shown to improve outcomes for these patients.

PURPOSE/HYPOTHESIS: Our objective was to assess the impact of a three-pronged education package on the knowledge and attitudes of emergency physicians towards using buprenorphine for treatment of OUD. Procedures/data/observations: We developed a three-pronged educational package including back- ground rationale for OUD treatment with buprenorphine, an evidence-based ED buprenorphine induction pathway and electronic medical record tools. This package was deployed to providers in an urban academic ED. A voluntary confidential pre-post survey was administered. Using a 6-point Likert Scale, participants were asked about their understanding, experience, and confidence with prescribing.

CONCLUSIONS/APPLICATIONS: A one-hour, three-pronged educational package changed the attitudes of emergency physicians towards buprenorphine treatment and demonstrated an increase in willingness and confidence to prescribe it for patients with OUD. Our findings suggest that healthcare entities that wish to boost buprenorphine prescribing can impact willingness and confidence to prescribe with a short education package.

摘要

背景

阿片类药物过量仍是发病率和死亡率的主要原因。丁丙诺啡是治疗阿片类药物使用障碍(OUD)患者的重要药物,在急诊科(ED)启动丁丙诺啡治疗已被证明可改善这些患者的预后。

目的/假设:我们的目的是评估三管齐下的教育方案对急诊医师使用丁丙诺啡治疗 OUD 的知识和态度的影响。

程序/数据/观察:我们制定了一个三管齐下的教育方案,包括丁丙诺啡治疗 OUD 的背景原理、基于证据的 ED 丁丙诺啡诱导途径和电子病历工具。该方案已部署到城市学术急诊科的医务人员。我们进行了一项自愿的、保密的、预-后问卷调查。参与者使用 6 分制 Likert 量表,被问及他们对丁丙诺啡治疗的理解、经验和信心。

结论/应用:一个小时的三管齐下的教育方案改变了急诊医师对丁丙诺啡治疗的态度,并显示出增加了为 OUD 患者开具丁丙诺啡的意愿和信心。我们的发现表明,希望增加丁丙诺啡处方量的医疗保健机构可以通过简短的教育方案来影响开具处方的意愿和信心。

相似文献

1
Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine/Naloxone for Opioid Use Disorder.教育模块对急诊医师开具丁丙诺啡/纳洛酮治疗阿片类药物使用障碍知识和态度的影响。
J Opioid Manag. 2024 Jul-Aug;20(4):B13. doi: 10.5055/bupe.24.rpj.1095.
2
Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.在急诊科开始使用丁丙诺啡:对急诊临床医生的调查。
West J Emerg Med. 2024 Jul;25(4):470-476. doi: 10.5811/westjem.18029.
3
Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.评估急诊科用于治疗阿片类药物使用障碍的药物:2020 年国家医院门诊医疗调查的横断面分析。
Am J Emerg Med. 2024 Aug;82:52-56. doi: 10.1016/j.ajem.2024.05.015. Epub 2024 May 20.
4
Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.解决急诊科启动丁丙诺啡治疗中存在的制度和临床障碍:干预后医生结局评估。
West J Emerg Med. 2024 May;25(3):303-311. doi: 10.5811/westjem.18320.
5
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍:基于诊室的门诊治疗能否解决美国的阿片类药物危机?
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
6
Attitudinal barriers to buprenorphine prescription and former waiver training.阿片类物质使用障碍患者对丁丙诺啡处方和先前豁免培训的态度障碍。
J Opioid Manag. 2024 Jul-Aug;20(4):339-346. doi: 10.5055/jom.0827.
7
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.在美国商业保险人群中,接受阿片类药物使用障碍治疗的个体中,可注射纳曲酮、口服纳曲酮和丁丙诺啡的使用和停药情况。
J Subst Abuse Treat. 2018 Feb;85:90-96. doi: 10.1016/j.jsat.2017.07.001. Epub 2017 Jul 3.
8
Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.为被认为有阿片类药物使用障碍高风险的急诊科患者提供纳洛酮。
Am J Emerg Med. 2021 Feb;40:173-176. doi: 10.1016/j.ajem.2020.10.061. Epub 2020 Nov 11.
9
A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD).简短的教育干预以增加急诊科对阿片类药物使用障碍(OUD)患者使用丁丙诺啡的启动率。
J Med Toxicol. 2022 Jul;18(3):205-213. doi: 10.1007/s13181-022-00890-7. Epub 2022 Apr 12.
10
A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions.在处方限制减少的时代,急诊医师实用的丁丙诺啡使用回顾。
Am J Emerg Med. 2021 Oct;48:316-322. doi: 10.1016/j.ajem.2021.06.065. Epub 2021 Jul 5.